The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial

E Chomba; K Klein; Elizabeth McClure; D Colaci; Vanessa Thorsten; PL Hibberd; F Esamai; A Garces; A Patel; S Saleem; O Pasha; WA Carlo; NF Krebs; S Goudar; RJ Derman; EA Liechty; M Koso-Thomas; PM Buekens; JM Belizan; RL Goldenberg; F Althabe

doi:doi:10.1186/s12978-016-0179-z

The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial

Klein, K., McClure, E., Colaci, D., Thorsten, V., Hibberd, PL., Esamai, F., Garces, A., Patel, A., Saleem, S., Pasha, O., Chomba, E., Carlo, WA., Krebs, NF., Goudar, S., Derman, RJ., Liechty, EA., Koso-Thomas, M., Buekens, PM., Belizan, JM., ... Althabe, F. (2016). The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial. Reproductive Health, 13, e64. https://doi.org/10.1186/s12978-016-0179-z

Copy citation

Abstract

BACKGROUND: The Antenatal Corticosteroid Trial (ACT) assessed the feasibility, effectiveness, and safety of a multifaceted intervention to increase the use of antenatal corticosteroids (ACS) in mothers at risk of preterm birth at all levels of care in low and middle-income countries. The intervention effectively increased the use of ACS but had no overall impact on neonatal mortality in the targeted

The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial

Abstract

Publications Info

Meet the Experts

Elizabeth McClure

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination

Article

Community engagement to implement evidence-based practices in the HEALing Communities Study

Article

Cannabinoid receptor subtype influence on neuritogenesis in human SH-SY5Y cells

Article

Operationalizing and selecting outcome measures for the HEALing Communities Study